Adalat and Hepatic disorder aggravated - a phase IV clinical study of FDA data
Hepatic disorder aggravated is found among people who take Adalat, especially for people who are male, 60+ old, have been taking the drug for < 1 month.
The phase IV clinical study analyzes which people take Adalat and have Hepatic disorder aggravated. It is created by eHealthMe based on reports of 20,024 people who have side effects when taking Adalat from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.
20,024 people reported to have side effects when taking Adalat.
Among them, 33 people (0.16%) have Hepatic disorder aggravated.
What is Adalat?
Adalat has active ingredients of nifedipine. It is often used in high blood pressure. eHealthMe is studying from 19,965 Adalat users for its effectiveness, alternative drugs and more.
What is Hepatic disorder aggravated?
Hepatic disorder aggravated is found to be associated with 305 drugs and 35 conditions by eHealthMe.
Number of Adalat and Hepatic disorder aggravated reports submitted per year:
Time on Adalat when people have Hepatic disorder aggravated *:
- < 1 month: 100 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
Gender of people who have Hepatic disorder aggravated when taking Adalat *:
- female: 39.39 %
- male: 60.61 %
Age of people who have Hepatic disorder aggravated when taking Adalat *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 3.33 %
- 30-39: 3.33 %
- 40-49: 0.0 %
- 50-59: 20.0 %
- 60+: 73.33 %
Common drugs people take besides Adalat *:
- Mexitil: 10 people, 30.30%
- Lasix: 8 people, 24.24%
- Famotidine: 7 people, 21.21%
- Diovan: 6 people, 18.18%
- Halcion: 5 people, 15.15%
- Lescol: 5 people, 15.15%
- Losartan Potassium: 5 people, 15.15%
- Pletal: 5 people, 15.15%
- Prednisolone: 3 people, 9.09%
- Amlodipine Besylate: 3 people, 9.09%
Common side effects people have besides Hepatic disorder aggravated *:
- Liver Function Tests Nos Abnormal: 8 people, 24.24%
- Blood Bilirubin Increased: 8 people, 24.24%
- Fever: 7 people, 21.21%
- Erythema Multiforme (a type of hypersensitivity reaction): 6 people, 18.18%
- Toxicoderma (a disease of the skin caused by a toxic agent): 6 people, 18.18%
- Hypotension (abnormally low blood pressure): 6 people, 18.18%
- White Blood Cell Count Increased: 5 people, 15.15%
- Thrombocytopenia (decrease of platelets in blood): 5 people, 15.15%
- High Blood Cholesterol: 5 people, 15.15%
- Acute Circulatory Failure (shock): 4 people, 12.12%
Common conditions people have *:
- Gastric Ulcer (stomach ulcer): 3 people, 9.09%
* Approximation only. Some reports may have incomplete information.
Do you take Adalat and have Hepatic disorder aggravated?Check whether Hepatic disorder aggravated is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Alternative drugs to, pros and cons of Adalat:
- Adalat (19,965 reports)
Hepatic disorder aggravated treatments and more:
- Hepatic disorder aggravated (13 reports)
COVID vaccines that are related to Hepatic disorder aggravated:
- Hepatic disorder aggravated in Moderna COVID Vaccine
- Hepatic disorder aggravated in Pfizer BioNTech Covid Vaccine
- Hepatic disorder aggravated in Johnson and Johnson Covid Vaccine
How severe was Hepatic disorder aggravated and when was it recovered:
Expand to all the drugs that have ingredients of nifedipine:
Common drugs associated with Hepatic disorder aggravated:
- Furosemide: 113 reports
- Lipitor: 155 reports
- Pepcid: 104 reports
- Prednisolone: 133 reports
- Prednisone: 118 reports
All the drugs that are associated with Hepatic disorder aggravated:
- Hepatic disorder aggravated (306 drugs)
All the conditions that are associated with Hepatic disorder aggravated:
- Hepatic disorder aggravated (35 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on nifedipine (the active ingredients of Adalat) and Adalat (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.